Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Informed consent for cancer registration

J Dudeck

    The Lancet. Oncology
    |March 22, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Giessen Tumor Documentation System (GTDS)--review and perspectives.

    Methods of information in medicine·2006
    Same author

    Representation of practice guidelines with XML--modeling with XML schema.

    Methods of information in medicine·2002
    Same author

    Integrated decision support in a hospital cancer registry.

    Artificial intelligence in medicine·2002
    Same author

    Presentation of problem-specific, text-based medical knowledge: XML and related technologies.

    Proceedings. AMIA Symposium·2002
    Same author

    DTDs go XML schema--a tools perspective.

    Medical informatics and the Internet in medicine·2002
    Same author

    Towards case-based performance measures: uncovering deficiencies in applied medical care.

    Journal of evaluation in clinical practice·2001
    Same journal

    Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

    The Lancet. Oncology·2026
    Same journal

    Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026
    Same journal

    Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

    The Lancet. Oncology·2026
    Same journal

    European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

    The Lancet. Oncology·2026
    Same journal

    Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

    The Lancet. Oncology·2026
    Same journal

    Correction to Lancet Oncol 2025; 26: e369-80.

    The Lancet. Oncology·2026
    See all related articles